News
GLP-1 RAs are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.
For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback